Influence of Dexmedetomidine and Lidocaine on Opioid Consumption, Cognitive Function and Incidence of Neuropathic Pain in Laparoscopic Intestine Resection

Trial Profile

Influence of Dexmedetomidine and Lidocaine on Opioid Consumption, Cognitive Function and Incidence of Neuropathic Pain in Laparoscopic Intestine Resection

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Dexmedetomidine (Primary) ; Fentanyl; Lidocaine
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2016 Status changed from active, no longer recruiting to completed.
    • 02 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top